Valeo Financial Advisors’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-4
| Closed | -$2.73K | – | 682 |
|
|
2023
Q3 | $2.73K | Hold |
4
| – | – | ﹤0.01% | 618 |
|
|
2023
Q2 | $18.1K | Hold |
4
| – | – | ﹤0.01% | 585 |
|
|
2023
Q1 | $10.5K | Hold |
4
| – | – | ﹤0.01% | 608 |
|
|
2022
Q4 | $10.3K | Hold |
4
| – | – | ﹤0.01% | 535 |
|
|
2022
Q3 | $15K | Hold |
4
| – | – | ﹤0.01% | 478 |
|
|
2022
Q2 | $10K | Buy |
+4
| New | +$10K | ﹤0.01% | 481 |
|
|
2021
Q2 | – | Sell |
-1
| Closed | -$15K | – | 1810 |
|
|
2021
Q1 | $15K | Buy |
+1
| New | +$15K | ﹤0.01% | 1188 |
|